|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 452.25 INR | +0.62% |
|
-2.24% | +2.35% |
| 05-23 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-22 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 20.68B 219M 189M 174M 164M 307M 310M 2.06B 802M 10.15B 822M 805M 35.11B | P/E 2024 |
-48.8x | P/E 2025 | 35.6x |
|---|---|---|---|---|---|
| Enterprise Value | 24.38B 258M 223M 205M 193M 362M 365M 2.43B 945M 11.97B 970M 949M 41.4B | EV / Sales 2024 |
2.07x | EV / Sales 2025 | 2.49x |
| Free-Float |
28.71% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.62% | ||
| 1 week | -2.24% | ||
| Current month | +29.45% | ||
| 1 month | +20.62% | ||
| 3 months | +40.04% | ||
| 6 months | -0.01% | ||
| Current year | +2.35% |
| 1 week | 426.7 |  | 467.9 |
| 1 month | 339.5 | | 515.95 |
| Current year | 278.2 | | 515.95 |
| 1 year | 278.2 | | 657.95 |
| 3 years | 278.2 | | 937.95 |
| 5 years | 198 | | 937.95 |
| 10 years | 80 | | 937.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 77 | 05/02/2024 | |
| Chairman | 73 | 22/08/1977 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.62% | -2.24% | - | - | 336M | |
| -0.94% | -2.14% | +40.54% | +148.38% | 992B | |
| -0.42% | -1.80% | +53.69% | +42.60% | 564B | |
| -0.56% | -1.65% | +19.27% | +59.57% | 391B | |
| -1.18% | +0.68% | +24.66% | +16.53% | 330B | |
| +1.42% | +0.06% | +26.36% | +14.29% | 280B | |
| +1.09% | +1.65% | +26.61% | +33.32% | 279B | |
| +1.87% | +0.87% | -41.49% | -48.26% | 196B | |
| -1.78% | +1.16% | +17.79% | +48.77% | 184B | |
| -1.40% | +3.27% | +16.16% | +59.08% | 156B | |
| Average | -0.13% | +0.41% | +20.40% | +41.59% | 374.58B | |
| Weighted average by Cap. | -0.37% | -0.49% | +29.25% | +65.83% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.05B 181M 156M 143M 135M 253M 256M 1.7B 661M 8.37B 678M 664M 28.95B | 21.11B 224M 193M 177M 167M 314M 316M 2.1B 819M 10.36B 840M 822M 35.84B |
| Net income | -705M -7.47M -6.44M -5.92M -5.57M -10.48M -10.56M -70.19M -27.33M -346M -28.03M -27.43M -1.2B | 1.38B 14.57M 12.57M 11.56M 10.88M 20.44M 20.61M 137M 53.32M 675M 54.69M 53.52M 2.33B |
| Net Debt | 953M 10.09M 8.71M 8.01M 7.54M 14.16M 14.28M 94.88M 36.94M 468M 37.89M 37.08M 1.62B | 3.7B 39.23M 33.84M 31.11M 29.28M 55.03M 55.49M 369M 144M 1.82B 147M 144M 6.29B |
Employees
3,142
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 452.25 ₹ | +0.62% | 110,172 |
| 17/06/26 | 449.45 ₹ | +0.69% | 393,603 |
| 16/06/26 | 446.35 ₹ | +1.45% | 803,265 |
| 15/06/26 | 439.95 ₹ | -1.71% | 603,085 |
| 12/06/26 | 447.60 ₹ | -3.24% | 2,033,442 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
